SNPSSynopsys, Inc.

$509.92+6.2% 1Y

Is the business good?

Mixed

The checks split: earnings fully cash-backed (4.4×), but 3 of 9 health tests passed and margins compressing.

1 good, 2 to watch, 1 neutral
Fundamental health (F-score)3 / 9SEC EDGAR · Oct 31, 2025

Weak, deteriorating fundamentals. Nine pass/fail tests of year-over-year health from the filings.

Profits arrive as cash4.42×derived · Jul 31, 2026

Operating profit is fully backed by cash. Conversion is improving vs a year ago.

Margin direction, 3 years−5.2 pts

Operating profit is falling even as sales grow, costs are outrunning the top line.

Where ROE comes from2% ROA

A balanced mix of margins, efficiency, and leverage. ROE 4% = margin × turnover × leverage.

Unless marked, from derived.

Against the whole market›

Percentile against every name Ryufin tracks. Higher is better; the tick marks the middle of the market. Context, not one of the checks above.

FCF conversiontop 7% of the market
Leverage (Debt/EBITDA)behind 78% of the market

Where this answer is blind. The F-score rewards improvement, so an already-elite company can score mid-pack.

How good a business is SNPS?

Synopsys, Inc. earns 1.7% on the capital it employs against a 9.0% cost of capital, so growth costs more than it returns.

1.7%

Return on invested capital · cost of capital 9.0% · 7.3 points below what the capital costs: growth destroys value

Operating margin
8.5%

Operating margin · Software - Infrastructure median 5.8% · 12 months to Q3 2026

Cash conversion
4.42×

Cash conversion · 1.36× a year ago · operating cash flow covers the operating profit after tax

Share count, year on year
+19%

Share count, year on year · shareholders own a smaller slice than a year ago

Operating margin by fiscal year
YearOperating margin
FY202017%
FY202117%
FY202223%
FY202324%
FY202422%
FY202513%
Details›
Gross margin12 months to Q3 2026
72%
Operating margin12 months to Q3 2026
8.5%
Net margin12 months to Q3 2026
11%
Free cash flow margin
29%
R&D as % of revenue
31%
Revenue, trailing twelve months
$9.42B
Free cash flow, trailing twelve months
$2.75B
Net income, trailing twelve months
$1.08B
Return on invested capitaloperating profit after tax ÷ debt + equity − cash
1.7%

Margins, capital and share counts from the statements as filed with the SEC; cash conversion is operating cash flow over operating profit after tax.